25 February 2021
  • 12:47 pm Pakistan schools to resume regular classes from March 1
  • 12:32 pm Corporal punishment shouldn’t be used to discipline students: Shehzad Roy
  • 12:32 pm Police officer suspended for aerial firing at Nawabshah wedding
  • 11:47 am Three injured in Khuzdar explosion
  • 11:32 am Faisalabad man attacked for ‘peeping into neighbour’s house’
Choose Language
 Edit Translation
My-Ads
Spread the News

Brazil has fully approved the COVID-19 vaccine developed by Pfizer and BioNTech, its health regulator said on Tuesday, though a dispute over a supply deal means it has none to start an immunization program with.
It is the first coronavirus shot to receive full approval in Brazil, regulator Anvisa said. Vaccines developed by AstraZeneca and China’s Sinovac Biotech, have only been approved for emergency use.
The approval is good news for a country whose immunization campaign has been plagued by delays and political squabbling. However, it is unclear whether this will pave the way for a supply deal of a highly effective shot that is being rolled out globally.
“We hope to be able to move forward in our negotiations with the Brazilian government to support the immunization of the country’s population,” Pfizer’s Brazil boss Marta Diez said in a statement, without giving further details.
Brazil’s Health Ministry did not respond to a request for comment.
President Jair Bolsonaro has criticized the terms of a deal proposed by Pfizer, saying it is overly onerous as it exempts the U.S. firm from potential liability for unforeseen problems. Pfizer has said other countries, including Brazil’s neighbors in Latin America, have agreed to those terms.

Abdul Gh Lone

RELATED ARTICLES